Global Urinary Incontinence Market Segmentation, By Diagnosis (Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples), Type (Stress Incontinence, Urge Incontinence, Overflow Incontinence), Treatment Type (Medication, Devices, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
Urinary Incontinence Market Analysis
In recent years, the urinary incontinence market is anticipated to grow rapidly during the forecast period. According to the study "Prevalence of Urinary Incontinence among Young Healthy Females in Gujarat - A Cross-sectional Study," the prevalence of UI was 71.85 percent among young women aged 18-25 years who were healthy, with 50.85 percent having stress, 9.16 percent having urge, and 40 percent having a mixed type of urinary incontinence after an 11-month study period from December 2017 to October 2018, among the total population. Several organizations are now working on devices designed specifically for women. They're launching a variety of small, tampon-like disposable devices for daily use, as well as flexible silicone rings to prevent urine leakage and support the urethra in women with vaginal prolapse.
Urinary Incontinence Market Size
Global urinary incontinence market size was valued at USD 13.42 billion in 2024 and is projected to reach USD 23.57 billion by 2032, with a CAGR of 7.30% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
Attributes
Urinary Incontinence Key Market Insights
Segmentation
By Diagnosis: Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples
By Type: Stress Incontinence, Urge Incontinence, Overflow Incontinence
By Treatment Type: Medication, Devices, Others
By Route of Administration: Oral, Parenteral, Others
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
By End User: Hospitals, Specialty Clinics, Homecare, Others
Countries Covered
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Key Market Players
Zydus Cadila (India), Torrent Pharmaceuticals Ltd. (India), Apotex Inc., Eli Lilly and Company (US), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd. (Israel), Alembic Pharmaceuticals Limited (India), Coloplast Group (Denmark), Boston Scientific Corporation (US), Alembic Pharmaceuticals Limited (India), B. Braun Melsungen AG (Germany), BD (US), Baxter (US), Johnson & Johnson Private Limited (US), Medtronic (Ireland), AstraZeneca (UK), Merck & Co., Inc. (US)
Market Opportunities
Increase in the number of emerging markets
Increase in the number of research and development activities
Rising investment for the development of advanced technologies
Surging drug approvals and launches
Urinary Incontinence Market Definition
Incontinence is the term for any unintentional urine leaking. Male urine incontinence is most frequently caused by a damaged sphincter or a faulty bladder. In the bladder, the sphincter is a circular muscle that controls urine flow. When the urethra, the tube that takes urine from the bladder to the outside of the body, is wounded, this muscle loses its capacity to squeeze and close it. Urinary incontinence devices help with urine collection and retention, as well as urinary incontinence management. Urinary incontinence is a condition in which pee leaks out uncontrollably.
Urinary Incontinence Market Dynamics
Drivers
Rise in the prevalence of urinary incontinence
The increased prevalence of urinary incontinence is a major factor driving market expansion (UI). Urinary incontinence symptoms can be caused by a variety of reasons, including urinary tract infection, weakening of pelvic floor muscles and urethral sphincters, menopause, pregnancy, childbirth, and post-radical prostatectomy surgery in men.
Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of urinary incontinence market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness and increasing number of cases of diabetes, obesity and neurological diseases will expand the urinary incontinence market. Additionally, high disposable income and increasing trend of non-invasive treatment options will result in the expansion of urinary incontinence market. Along with this, rising geriatric population and rising incidences of chronic diseases will enhance the growth rate of the market. Surge in the consumption of sweeteners, caffeine, carbonated drinks, chocolates, sparkling water, muscle relaxants and artificial chili peppers can enhance the risk of urinary incontinence and hence further projected to cushion the market’s growth rate.
Opportunities
Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the urinary incontinence market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the urinary incontinence market growth during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with the treatment and devices will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies will challenge the urinary incontinence market. Additionally, the dearth of skilled professionals and complications involved with the procedures will act as restrain and further impede the growth rate of market during the forecast period of 2025-2032.
This urinary incontinence market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinary incontinence market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Urinary incontinence market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Urinary Incontinence Market Scope
The urinary incontinence market is segmented on the basis of diagnosis, type, treatment type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
The Urinary incontinence market is analyzed and market size insights and trends are provided by country, diagnosis, type, treatment type, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Urinary incontinence market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the urinary incontinence market because of the surging adoption of newer techniques in this region. Additionally, growing presence of major key players and well-established healthcare infrastructure will further propel the market’s growth rate in this region.
Asia-Pacific are expected to grow during the forecast period due to surging number of generic manufacturers and rising government initiatives in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Urinary Incontinence Market Share
The Urinary incontinence market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinary incontinence market.
Urinary Incontinence Market Leaders Operating in the Market Are:
Zydus Cadila (India)
Torrent Pharmaceuticals Ltd. (India)
Apotex Inc.
Eli Lilly and Company (US)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India)
Lupin (India)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Alembic Pharmaceuticals Limited (India)
Coloplast Group (Denmark)
Boston Scientific Corporation (US)
Alembic Pharmaceuticals Limited (India)
B. Braun Melsungen AG (Germany)
BD (US)
Baxter (US)
Johnson & Johnson Private Limited (US)
Medtronic (Ireland)
AstraZeneca (UK)
Merck & Co., Inc. (US)
Latest Developments in Urinary Incontinence Market
In May 2020, Rigicon had announced the launch of two new artificial urinary sphincter models named ContiClassic Artificial Urinary Sphincter and ContiReflex Artificial Urinary Sphincter. AUS stands for Artificial Urine Sphincter and is a medical device used to treat urinary incontinence. When non-surgical and behavioural treatment approaches fail, the Artificial Urinary Sphincter is a surgical treatment option.
SKU-53372
Get online access to the report on the World's First Market Intelligence Cloud
Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Claudio Rondena
Group Business Development & Strategic Marketing Director, C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice.
Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough.
Your work is much appreciated.
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics,
Ipsen Biopharm Limited
We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.
Competition Analyst,
Basler Web
I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.
Marketing Director,
Buhler Group
It was indeed a good experience, would definitely recommend and come back for future prospects.
COO,
A global leader providing Drug Delivery Services
DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.
Marketing Director,
Philips Healthcare
The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.
Product manager,
Fujifilms
Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
Investor relations,
GE Healthcare
Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.
Market Analyst,
Medincell
We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.
Andrew - Senior Global Marketing Manager,
Medtronic (US)
I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.
Amarildo - Manager, Global Strategic Alignment
MasterCard
We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.
Tor Hammer
Green Nexus LLc
Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects
I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying.
Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.
Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)
Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future